EUVIMEDEUVIMED entdecken
Crossref

Contrast media hypersensitivity in oncology patients undergoing enhanced computed tomography: Risk stratification and nurse-led pre-procedural assessment

Lizhu Zhang, Dongqiang Guo, Hongli Liang

Cancer Plus · 05.06.2026 · 026020001

DOI: 10.36922/cp026020001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Plus, online erschienen am 05.06.2026. Verfasst von Lizhu Zhang und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study (n = 1,623) evaluated risk factors for iodinated contrast media (ICM)-induced hypersensitivity in oncology patients undergoing computed tomography scans, developed a risk-stratification model, and assessed the efficacy of a nurse-based pre-evaluation protocol. Patients from three hospitals were divided into an intervention group that received a nurse-facilitated pre-assessment (n = 812) and a control group that followed standard protocols (n = 811). The overall incidence of ICM hypersensitivity was 3.2%. Multivariate analysis revealed that lung cancer (odds ratio [OR] = 2.13) and recent chemotherapy (OR = 2.87) are significant independent risk factors. A newly developed risk stratification model incorporating these attributes categorized patients into low, intermediate, and high-risk groups, with hypersensitivity rates of 1.2%, 4.5%, and 7.8%, respectively. Furthermore, the nurse-based pre-assessment intervention significantly lowered overall hypersensitivity rates (1.8% vs. 4.6%) and moderate-to-severe reactions (0.2% vs. 2.0%) compared to the control group, offering notable protection particularly for high-risk subgroups. In conclusion, lung cancer and recent chemotherapy strongly predict ICM hypersensitivity in cancer patients. Implementing a risk-stratification model based on these factors, combined with a dedicated nurse pre-assessment protocol, significantly reduces hypersensitivity incidents and enhances imaging safety for this vulnerable population.

Zitieren

APA

Zhang, L., Guo, D., & Liang, H. (2026). Contrast media hypersensitivity in oncology patients undergoing enhanced computed tomography: Risk stratification and nurse-led pre-procedural assessment. Cancer Plus, 0(0), 026020001. https://doi.org/10.36922/cp026020001

Vancouver

Zhang L, Guo D, Liang H. Contrast media hypersensitivity in oncology patients undergoing enhanced computed tomography: Risk stratification and nurse-led pre-procedural assessment. Cancer Plus. 2026;0(0):026020001. doi:10.36922/cp026020001

BibTeX
@article{Zhang2026,
  author = {Zhang, Lizhu and Guo, Dongqiang and Liang, Hongli},
  title = {Contrast media hypersensitivity in oncology patients undergoing enhanced computed tomography: Risk stratification and nurse-led pre-procedural assessment},
  journal = {Cancer Plus},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {026020001},
  doi = {10.36922/cp026020001}
}
Kostenlos starten →